Introduction: Hysterectomy is routinely performed laparoscopically. It has many advantages as compared to open abdominal hysterectomy such as less post operative pain, better cosmetic results, shorter hospital stay, lower complication rate. However Laparoscopic surgeries are routinely performed under general anaesthesia with endotracheal intubation to prevent aspirations of gastric contents and respiratory embarrassment secondary to pneumoperitoneum. But it has several disadvantages like hemodynamic instability, postoperative nausea and vomiting, increased postoperative analgesic requirement, complications related to intubation or extubation and postoperative sore throat. Material and Methods: After the approval of institutional ethics committee and written informed consent 24 ASA grade 1 and 2 patients in the age group of 35 to 55 years underwent total laparoscopic hysterectomy under spinal anaesthesia with intrathecal bupivacaine and fentanyl. Exclusion criteria included those with presence of any condition contraindicating elective surgery or spinal anaesthesia. The patients were explained during pre-operative visit about the procedure and also told that any anxiety, pain, or discomfort during the surgery would be dealt with intravenous medications or if required conversion to general anaesthesia. Results: In our study 24 patients were taken for total laparoscopic hysterectomy during the period of Aug 2022 to Nov 2022.. Age group of patients between 40 to 60 years. All the 24 surgeries were completed laparoscopically. Average duration for surgery is 90 min (60- 120min). None of the patient required conversion to general anaesthesia. Intraoperative parameters including blood pressure, pulse rate, spo2 and respiratory rate were all within normal limits. 8 patients required pharmacological intervention for hypotension with one time support of inj mephentermine 6mg. 6 patients required inj. glycopyrolate 0.2mg for bradycardia (HR less than 50). Patients were catheterised preoperatively. There was no case of PDPH. All the patients received inj pentazocine 30mg in divided doses for shoulder tip pain. None of the patient developed respiratory depression or required assistance for ventilation.